This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Kimberly-Clark (KMB) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Kimberly-Clark's (KMB) fourth-quarter 2020 results are likely to reflect gains from pandemic-induced demand, while softness in the K-C Professional unit is a concern.
3 Factors That Makes Helen of Troy (HELE) a Promising Pick
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in its Leadership Brands. Also, strength in the company's online business is yielding.
Coty (COTY) Gains on Brand Strength & E-Commerce Amid Low Traffic
by Zacks Equity Research
Coty (COTY) has been gaining on its focus on innovation and strength in the e-commerce channel. However, soft traffic and disrupted travel retail amid the pandemic are hurdles.
Things to Note Ahead of Procter & Gamble's (PG) Q2 Earnings
by Zacks Equity Research
Procter & Gamble (PG) Q2 performance is likely to have benefited from the pandemic-led cleaning frenzy among consumers, which has led to escalated demand for cleaning products.
Inter Parfums' (IPAR) Subsidiary to Buy Office Building Complex
by Zacks Equity Research
Inter Parfums' (IPAR) subsidiary Interparfums SA to buy property in Paris, which will be used as its headquarters. Management expects to close the transaction during spring of 2021.
International Flavors (IFF) Issues Guidance on DuPont Integration
by Zacks Equity Research
International Flavors (IFF) projects run rate revenue synergies of $400 million by the end of 2023.
Nu Skin (NUS) Looks Buoyant, Stock Up More Than 35% in a Year
by Zacks Equity Research
Nu Skin (NUS) has been benefiting from focus on innovation as well as commitment to strengthening sales leaders.
Estee Lauder (EL) Looks Solid on Online Business & Savings
by Zacks Equity Research
Estee Lauder (EL) is implementing new technology and digital experiences to boost online sales. Also, strength in the Skin Care category is driving growth.
Are You Looking for a Top Momentum Pick? Why Estee Lauder (EL) is a Great Choice
by Zacks Equity Research
Does Estee Lauder (EL) have what it takes to be a top stock pick for momentum investors? Let's find out.
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Estee Lauder (EL) Up Nearly 25% YTD, Will Momentum Stay in 2021?
by Zacks Equity Research
Estee Lauder's (EL) brand teams have been fully committed to enhancing consumer experiences online since the coronavirus outbreak. Also, the company's saving efforts are yielding.
Why Is Estee Lauder (EL) Up 10% Since Last Earnings Report?
by Zacks Equity Research
Estee Lauder (EL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Estee Lauder (EL) Gains on Solid Online Business & Savings
by Zacks Equity Research
Estee Lauder (EL) is benefiting from its robust e-commerce business, especially amid the COVID-19 outbreak. Also, its solid presence in emerging markets is impressive.
NUS or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: NVIDIA, Netflix, Starbucks, Pfizer, Estee Lauder and Stryker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, Netflix, Starbucks, Pfizer, Estee Lauder and Stryker
Top Stock Reports for NVIDIA, Netflix & Starbucks
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Netflix (NFLX) and Starbucks (SBUX).
Company News for Nov 3, 2020
by Zacks Equity Research
Companies In The News Are: CLX, EL, NLSN, NCLH
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Wall Street Waits for U.S. Presidential Election
by Zacks Equity Research
Wall Street Waits for U.S. Presidential Election
Election Day: A Cure for Uncertainty?
by Mark Vickery
We start a new month in a more hopeful mood, after a rough October that lived up to its historical billing of the month most difficult to make money in equities.
Estee Lauder (EL) Beats Q1 Earnings Estimates, Hikes Dividend
by Zacks Equity Research
Estee Lauder's (EL) first-quarter fiscal 2021 sales and earnings fall year over year. Results reflect adverse impact of some retail store closures and lower traffic in reopened stores amid COVID-19.
Estee Lauder (EL) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 60.00% and 2.15%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Things You Should Know About Clorox (CLX) Ahead of Q1 Earnings
by Zacks Equity Research
Clorox's (CLX) Q1 top line is likely to have gained from continued strong product demand and growth across segments. Higher costs and investments to meet demand are likely to have hurt margins.
Why Earnings Season Could Be Great for Estee Lauder (EL)
by Zacks Equity Research
Estee Lauder (EL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Estee Lauder (EL) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Adverse impacts of coronavirus-induced temporary store closures and sluggishness in travel retail are likely to get reflected in Estee Lauder's (EL) first-quarter fiscal 2021 performance.